Quantitative Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-358,800
Closed -$4.46M 1028
2016
Q4
$4.46M Buy
+358,800
New +$4.32M 0.11% 289
2016
Q3
Sell
-85,200
Closed -$629K 980
2016
Q2
$629K Sell
85,200
-14,400
-14% -$108K 0.03% 508
2016
Q1
$636K Buy
99,600
+39,500
+66% +$221K 0.03% 501
2015
Q4
$375K Sell
60,100
-176,800
-75% -$1.16M 0.02% 548
2015
Q3
$1.38M Buy
+236,900
New +$1.83M 0.1% 242
2015
Q2
Sell
-60,400
Closed -$497K 791
2015
Q1
$497K Buy
60,400
+11,500
+24% +$85K 0.05% 349
2014
Q4
$335K Buy
+48,900
New +$306K 0.05% 325
2013
Q4
Sell
-57,100
Closed -$1.05M 778
2013
Q3
$1.05M Buy
+57,100
New +$1.11M 0.09% 210

Other funds holding ARIA

Quantitative Investment Management's ARIA Position: Q1 2017 in Review

Quantitative Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 358,800 shares — an estimated $4.46M sold.

Quantitative Investment Management first reported a position in ARIA in Q3 2013 and held it in 8 quarters. The position peaked at $4.46M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Quantitative Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 358,800 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $4.46M.
  • Quantitative Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
  • Quantitative Investment Management's Ariad Pharmaceuticals Inc position peaked at $4.46M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Quantitative Investment Management's 13F filing for Q1 2017, filed 8 May 2017.